Adarx Pharmaceuticals Inc.

3 trials 2 recruiting Commercial sponsor

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

2 Recruiting

0 Completed trials

12 Countries active

3 Unique IMPs

N/A Results reported

Phase III

Phase II

Phase III: 1 Phase II: 2

Top indications

Hereditary angioedema 1 Immune-mediated renal disorder 1

Top IMPs

ADX-038 2 ADX-324 1 SODIUM CHLORIDE 1

All trials

3 total

A clinical trial to assess the efficacy and safety of ADX-308, a new type of treatment for Geographic Atrophy (GA), an advanced stage of eye… Pending

2025-521779-30-00 Phase II 4 countries ADX-038; SODIUM CHLORIDE
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease Recruiting

2025-521752-26-00 Phase II 2 countries ADX-038
STOP-HAE: A Phase 3 Study of ADX-324 in HAE Recruiting

2025-521352-38-00 Phase III 11 countries ADX-324

Showing 1–3 of 3 trials

← All sponsors A–Z